Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir-the company’s twice-yearly ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--#GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health ...

The startup sells cyber protection systems to companies with complex or old physical infrastructures, such as gas rigs, electricity companies, and nuclear reactors.

The IndyCar Series has incorporated an important safety change during the offseason that will prompt its drivers when local yellow flags are active on road and street courses. Through the EM ...

16 analysts have shared their evaluations of Gilead Sciences GILD during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of ...

Progressive Washington state lawmakers have introduced a bill that could remove George Washington from the state flag. House Bill 1938 aims to create a committee that will design a new state flag ...

– Gilead Also Recently Submitted Applications for Lenacapavir for PrEP to the European Medicines Agency That Will Be Reviewed Under Accelerated Assessment Review Timeline – FOSTER CITY, ...

The FDA is giving this drug a priority review and expects to make a decision by June 19, 2025, according to a release. Gilead Sciences, Inc. recently announced that the FDA accepted its new drug ...

According to the Hebron Fire Department, at around 4:48 p.m. firefighters and troopers were deployed to the scene of Gilead Street for reports of a two-car accident involving a rollover.

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Gilead Sciences Inc (Symbol: GILD) were yielding above the 3% mark based on its quarterly dividend ...